Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the long-term safety and monitor the long-term efficacy of arformoterol over a
period of 6 months in subjects with chronic obstructive pulmonary disease (COPD).